Numerous studies have provided clear evidence that IL-6 C-174G single-nucleotide polymorphism was a risk factor in Type 2 diabetes and contributed to higher serum interleukin-6 level among the participants [4,27,28]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.